1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Immunocompromised: new trials by email Literature Review of Immunocompromised trials Research Report on Immunocompromised
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes - Hematopoietic and Lymphoid Cell Neoplasm, Immunocompromised | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 16 | 2018-03-15 | 2026-09-04 |
| A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis Micafungin - Immunocompromised, Bone Marrow Transplant | Phase 1 | Terminated | Children's Hospital Medical Center, Cincinnati | 9 | 2014-01-01 | 2018-05-23 |
Hematologic Neoplasms (1) · Leukemia, Myeloid, Acute (1) · Neoplasms (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia (1) · Leukemia, Myeloid (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
Micafungin (1)
Children's Hospital Medical Center, Cincinnati (1) · M.D. Anderson Cancer Center (1)
United States (2)
David Marin (1) · Parinda Mehta, MD (1)